Stryker announces new Vice President, Chief Legal Officer
March 27 2019 - 4:01PM
Stryker (NYSE:SYK) announced today that Rob Fletcher will be
joining the company as Vice President, Chief Legal Officer
effective April 22, 2019. Mike Hutchinson will be
transitioning from his current role to serve as Advisor to the
Chief Executive Officer through May 2020.
Mr. Hutchinson has most recently served as Vice President, Chief
Legal Officer responsible for the Legal, Compliance and Corporate
Secretary functions. “We would like to thank Mike for the many
contributions he has made to the company and for his demonstrated
commitment to our success and robust growth,” said Kevin Lobo,
Chairman and Chief Executive Officer. “Mike has strengthened our
global legal and compliance capabilities and guided our company
through many complex matters. I wish Mike the best in this new
chapter of his career."
Mr. Fletcher joins Stryker after almost 15 years at Johnson
& Johnson during which he held multiple legal leadership roles
including General Counsel for both the Medical Devices and
Pharmaceutical sectors. Most recently, Mr. Fletcher held the role
of Worldwide Vice President, Litigation. Mr. Fletcher brings
extensive global experience, demonstrated success in a large,
med-tech company and deep leadership experience managing complex
business issues and opportunities.
Prior to joining Johnson & Johnson, Mr. Fletcher served as
corporate counsel for General Electric Aircraft Engines, which
included significant work in mergers, acquisitions, joint ventures
and divestitures. Before GE, Mr. Fletcher was in private legal
practice at the Ohio law firm Katz Teller in the firm’s corporate
and real estate department. He earned his B.A. degree from The Ohio
State University and a J.D. from Boston College Law School.
Stryker is one of the world’s leading medical technology
companies and, together with its customers, is driven to make
healthcare better. The company offers innovative products and
services in Orthopaedics, Medical and Surgical, and Neurotechnology
and Spine that help improve patient and hospital outcomes. More
information is available at www.stryker.com.
Contacts
For investor inquiries please contact:Katherine
A. Owen, Vice President, Strategy & Investor Relations at
269-385-2600 or katherine.owen@stryker.com
For media inquiries please contact:Yin Becker,
Vice President, Communications, Public Affairs and Corporate
Marketing at 269-385-2600 or yin.becker@stryker.com
Stryker (NYSE:SYK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Stryker (NYSE:SYK)
Historical Stock Chart
From Jul 2023 to Jul 2024